维普中文期刊产品整合服务
17篇 您的检索式:作者名="Shereen E"
    题名 作者 年代 出处 被引量
1The pathogenesis of pituitary tumours显示文摘SYLVIA L A SHEREEN E 2002Nature2002,2,3:1
2The pathogenesis of pituitary turmours显示文摘 Shereen E 2002Nature2002,2,3:1
3The pathogenesis of pituitary turmours显示文摘Sylvia L A Shereen E 2002Nature2002,2,3:1
4HLA-DQB1 * 等位基因和基因危险性到类型 1 糖尿病 mellitus显示文摘 AIM: To determine human leukocyte antigen (HLA)DQB1 allele association with susceptibility to type 1 diabetes (T1D) and to clinical and laboratory findings. METHODS: This study was conducted on 85 unrelated Egyptian children with T1D recruited consecutively from the Pediatric Diabetes Endocrinology outpatients Clinic; Mansoura University Children’s Hospital, Egypt. Patient mean follow up period was 2.5 years. Patients were subdivided according to level of HbA1c (optimal/suboptimal control < 8.5% and poor control ≥ 8.5%). Thecontrol group consisted of 113 unrelated ageand sexmatched healthy subjects without T1D or other autoimmune diseases. Genomic DNA extraction was done for all subjects using a DNA isolation kit. HLA-Class Ⅱ-DQB1 allele typing was carried out with a polymerase chain reaction-sequence-specific oligonucleotide probe using a INNO-LiPA HLA-DQB1 update kit. RESULTS: Significant differences were detected between Egyptian patients with T1D and control groups in the frequencies of DQB1*02 [44.4% vs 18.6%, corrected P value (Pc) < 0.001] and DQB1*03 (41.2% vs 24.4%, Pc < 0.001). Significant differences were also observed between control groups and T1D patients in the frequencies of DQB1*05 (14.6% vs 7.2%, P = 0.029) and DQB1*06 (34.1% vs 7.2%, P < 0.001). However, after correction for multiple comparisons, the significance was retained for HLA-DQB1*06 (Pc < 0.001) but lost for HLA-DQB1*05. HLA-DQB1*0201, *0202, *030201 were positively associated with T1D (Pc = 0.014, Pc < 0.001, and Pc < 0.001 respectively), while HLA-DQB1*060101 was negatively associated (Pc < 0.001) with the condition. Although the HLA-DQB1 alleles 030101 and 050101 were significantly higher in controls (P = 0.016, P = 0.025 respectively), both of them lost statistical significance after correction of P value. The frequency of the HLA-DQB1 genotypes 02/02, 02/03, and 03/03 was higher in T1D patients, and the frequency of the genotypes 03/06, 05/06, and 06/06 was higher in controls, these differences being statistically significant before correction. After correction, the genotypes 02/02, 02/03 in T1D, and the genotypes 03/06, 06/06 in controls were still significant (Pc = 0.01, Pc < 0.001, Pc < 0.001, and Pc = 0.04, respectively). Non-significant associations were found between the frequency HLA-DQB1 alleles and genotypes in T1D in relation to the grade of diabetic control, Microalbuminuria, age, gender, age of presentation, weight, height, frequency of diabetic ketoacidosis (P =0.42), serum cholesterol, and fasting and post-prandial level of C-peptide (P = 0.83, P = 0.9, respectively). CONCLUSION: The Current work suggests that HLADQB1 alleles *030201, *0202, *0201, and genotypes 02/03, 02/02 may be susceptibility risk factors for development of T1D in Egyptian children, while the HLADQB1*060101 allele, and 03/06, 06/06 genotypes may be protective factors. HLA-DQB1 alleles and genotypes do not contribute to microalbuminuria or grade of diabetic control.Youssef M Mosaad Fatma A Auf Shereen S Metwally Ashraf A Elsharkawy Amany K El-Hawary Rasha H Hassan Ziyad E Tawhid Farha A El-Chennawi 2012World Journal of Diabetes2012,3,8:1
5Guidelines for the diagnosis and treatment of acromegaly:a Canadian perspective显示文摘Patel YC Shereen E Chick CL 2000Clin Invest Med2000,23,3:1
6Diagnosis and nmnagement of hyperprolaetinemia显示文摘Omar S Constance LC Shereen E 2003CMM2003,169,6:1
7Colorimetric and fluorimetric methods for determination of panthenol in cosmetic and pharmaceutical formulation显示文摘MOSTAFA A M SHEHATA SHEREEN M TAWAKKOL LAILA E ABDEL FATTAH 2002Journal of Pharmaceutical and Biomedical Analysis2002,27,5:1
8The pathogenesis of pituitary turmours 显示文摘Sylvia L A Shereen E 2002Nature2002,2,3:1
9Histone-acetylated control of fibrob- last growth factor receptor 2 intron 2 Polymorphisms and isoform Splic- ing in breast cancer 显示文摘Xuegong Z Sylvia LA Shereen E 2009Mol Endoerinol2009,23,9:1
10The pathogenesis of pituitary tumours 显示文摘Sylvia LA Shereen E 2002Nature2002,2,3:1
11Dual inhibition of RET and FGFR4 restrains medullary thyroid cancer cell growth 显示文摘Shereen E Ping H Alan D 2005Clin Cancer Res2005,11,3:1
12The Role of Hormones, Growth factors and their receptors in pituitary tumorigenesis 显示文摘Shereen E 2001Brain Pathol2001,11,3:1
13The role of hormones, growth factors and their receptors in pituitary tumorigenesis显示文摘Shereen E 2001Brain Pathol2001,11,3:1
14Guidelines for the diagnosis and treatment of acromegaly: a Canadian perspective 显示文摘Patel YC Shereen E Chick CL 2000Clin Invest Med2000,23,3:1
15The pathogenesis of pituitary tumors 显示文摘Sylvia L A Shereen E 2002Nature2002,2,3:1
16The pathogenesis of pituitary tumours显示文摘Sylvia L A Shereen E 2002Nature2002,2,3:1
17Vascular endothelial growth factor,p53,and the H-ras oncogene in Egyptian patients with bladder cancer显示文摘AIM:To evaluate the relationship between vascular endothelial growth factor(VEGF),p53,and the H-ras oncogene and different clinicopathological parameters in Egyptian patients with Schistosoma-associated transitional cell carcinoma of the bladder.METHODS:The study included 50 patients with transitional cell carcinoma for whom radical cystectomy and urinary diversions were carried out.VEGF and p53 protein expressions were evaluated with an immunohistochemical staining method,and H-ras oncogene mutations were analyzed with a polymerase chain reaction-restriction fragment length polymorphism(PCR-RFLP) technique.RESULTS:High grade tumors revealed higher p53 immunostaining than low grade tumors(P = 0.016).p53 and VEGF protein expressions,as well as H-ras oncogene mutations,had an insignificant impact on patient outcomes(P = 0.962,P = 0.791,and P = 967,respectively).Cancer extension to regional lymph nodes was associated with poor outcomes(P = 0.008).CONCLUSION:VEGF,p53 and the H-ras oncogene have no relation to patient survival and outcome in Schistosoma-associated transitional cell carcinoma.Farha A El-Chennawi Fatma A Auf Shereen S Metwally Youssef M Mosaad Atallah A Shaaban Mahmoud Abdo El-Baz Ziyad E Tawhid Zakaria F Lotfy 2009World Journal of Gastrointestinal Oncology2009,1,1:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费